
News|Videos|November 1, 2023
Advanced Prostate Cancer: Enhancing Combination Therapy
Author(s)David Morris, MD, FACS, Benjamin Garmezy, MD
Discover considerations for doublet or triplet therapy in advanced prostate cancer, analyzing the benefits and manageable added toxicity, as discussed by renowned experts in the field.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves Titan Prime Inflatable Penile Prosthesis
2
Enzalutamide associated with greater cognitive decline than darolutamide in advanced prostate cancer
3
FDA approves cefepime and zidebactam for complicated UTI
4
Phase 1 AcTION trial establishes RP2D for 225Ac-PSMA-617
5
















